FDA Adverse Event Malfunction Summary report: N

I-STAT ACT KAOLIN CARTRIDGE

MDR report key: 24578948 · Received March 12, 2026

Report

Report Number
2245578-2026-00051
Event Type
Malfunction
Date Received
March 12, 2026
Date of Event
February 2, 2026
Report Date
March 12, 2026
Manufacturer
ABBOTT POINT OF CARE INC.
Product Code
JBP
UDI-DI
10054749000156
PMA / PMN Number
K023582
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
WI, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

APOC INCIDENT#: (B)(4). APOC LABELING WILL BE EVALUATED DURING THE INVESTIGATION AS PERTAINING TO THE EVENT.

Description of Event or Problem · 0

ON 18-FEB-2026, ABBOTT POINT OF CARE WAS CONTACTED BY A CUSTOMER REGARDING I-STAT ACT KAOLIN CARTRIDGES THAT YIELDED A DISCREPANT RESULTS ON A PATIENT. THERE WAS NO PATIENT INFORMATION AVAILABLE. RETURN PRODUCT IS NOT AVAILABLE FOR INVESTIGATION. DATE: TESTED: RESULT (SECS) : ON (B)(6) 2026, 0911, 184, ON (B)(6) 2026, 0919, 179, ON (B)(6) 2026, 0934, 184, ON (B)(6) 2026, 1004, >1000, ON (B)(6) 2026, 1017, >1000, ON (B)(6) 2026, 1027, >1000, ON (B)(6) 2026, 1044, 179. THERE WAS NO HEPARIN TIME/DOSE INFORMATION. COLLECTED AND TESTED IMMEDIATELY. AT THIS TIME THERE IS NO REASON TO SUSPECT A MALFUNCTION EXISTS. THE REPORTING DECISION WAS BASED ON THE LIMITED INFORMATION AVAILABLE THAT SUGGESTS THE PRODUCT WAS NOT PERFORMING WITHIN THE VARIABILITY OF THE ASSAY. AN INVESTIGATION IS UNDERWAY. PER I-STAT SYSTEM MANUAL (ART: 714185-00Q), THE I-STAT KAOLIN ACTIVATED CLOTTING TIME (KAOLIN ACT) TEST IS AN IN VITRO DIAGNOSTIC TEST THAT USES FRESH, WHOLE BLOOD. AND IS USED TO MONITOR HIGH-DOSE HEPARIN ANTICOAGULATION FREQUENTLY ASSOCIATED WITH CARDIOVASCULAR SURGERY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
642226 I-STAT ACT KAOLIN CARTRIDGE ACT KAOLIN CARTRIDGE JBP ABBOTT POINT OF CARE INC. NA R25328 10054749000156

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown